|
1
|
Kitchener HC and Trimble EL: Endometrial
cancer state of the science meeting. Int J Gynecol Cancer.
19:134–140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sorosky JI: Endometrial cancer. Obstet
Gynecol. 111:436–447. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Barrena Medel NI, Bansal S, Miller DS,
Wright JD and Herzog TJ: Pharmacotherapy of endometrial cancer.
Expert Opin Pharmacother. 10:1939–1951. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen K, Zhang S, Ji Y, et al: Baicalein
inhibits the invasion and metastatic capabilities of hepatocellular
carcinoma cells via down-regulation of the ERK pathway. PLoS One.
8:e729272013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Weigel MT, Krämer J, Schem C, et al:
Differential expression of MMP-2, MMP-9 and PCNA in endometriosis
and endometrial carcinoma. Eur J Obstet Gynecol Reprod Biol.
160:74–78. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Karahan N, Güney M, Baspinar S, Oral B,
Kapucuoglu N and Mungan T: Expression of gelatinase (MMP-2 and
MMP-9) and cyclooxygenase-2 (COX-2) in endometrial carcinoma. Eur J
Gynaecol Oncol. 28:184–188. 2007.PubMed/NCBI
|
|
7
|
Naksuriya O, Okonogi S, Schiffelers RM and
Hennink WE: Curcumin nanoformulations: a review of pharmaceutical
properties and preclinical studies and clinical data related to
cancer treatment. Biomaterials. 35:3365–3383. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Likhter MS, Shelygin Iu A and Achkasov SI:
Multidisciplinary approach to the treatment of colorectal cancer,
complicated by urinary tract invasion. Khirurgiia (Mosk). 12:34–39.
2012.(In Russian). PubMed/NCBI
|
|
9
|
Chen J, Wang FL and Chen WD: Modulation of
apoptosis-related cell signalling pathways by curcumin as a
strategy to inhibit tumor progression. Mol Biol Rep. 41:4583–4594.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wong TF, Takeda T, Li B, et al: Curcumin
targets the AKT-mTOR pathway for uterine leiomyosarcoma tumor
growth suppression. Int J Clin Oncol. 19:354–363. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ranjan AP, Mukerjee A, Helson L, Gupta R
and Vishwanatha JK: Efficacy of liposomal curcumin in a human
pancreatic tumor xenograft model: inhibition of tumor growth and
angiogenesis. Anticancer Res. 33:3603–3609. 2013.PubMed/NCBI
|
|
12
|
Liang YJ, Hao Q, Wu YZ, Wang QL, Wang JD
and Hu YL: Aromatase inhibitor letrozole in synergy with curcumin
in the inhibition of xenografted endometrial carcinoma growth. Int
J Gynecol Cancer. 19:1248–1252. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu Z and Shah DM: Curcumin down-regulates
Ets-1 and Bcl-2 expression in human endometrial carcinoma HEC-1-A
cells. Gynecol Oncol. 106:541–548. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun W, Liu DB, Li WW, et al: Interleukin-6
promotes the migration and invasion of nasopharyngeal carcinoma
cell lines and upregulates the expression of MMP-2 and MMP-9. Int J
Oncol. 44:1551–1560. 2014.PubMed/NCBI
|
|
15
|
Park SL, Lee EJ, Kim WJ and Moon SK:
p27KIP1 is involved in ERK1/2-mediated MMP-9 expression via the
activation of NF-κB binding in the IL-7-induced migration and
invasion of 5637 cells. Int J Oncol. 44:1349–1356. 2014.PubMed/NCBI
|
|
16
|
Lee KR, Lee JS, Kim YR, Song IG and Hong
EK: Polysaccharide from Inonotus obliquus inhibits migration
and invasion in B16-F10 cells by suppressing MMP-2 and MMP-9 via
downregulation of NF-κB signaling pathway. Oncol Rep. 31:2447–2453.
2014.PubMed/NCBI
|
|
17
|
Lin HJ, Su CC, Lu HF, et al: Curcumin
blocks migration and invasion of mouse-rat hybrid retina ganglion
cells (N18) through the inhibition of MMP-2, -9, FAK, Rho A and
Rock-1 gene expression. Oncol Rep. 23:665–670. 2010.PubMed/NCBI
|
|
18
|
Qi Q, Dai M, Fan H, Zhang B and Yuan X:
Inhibitory effect of curcumin on MMP-2 and MMP-9 expression induced
by polyethylene wear particles and its mechanism. Zhongguo Xiu Fu
Chong Jian Wai Ke Za Zhi. 23:677–682. 2009.(In Chinese). PubMed/NCBI
|
|
19
|
Mitra A, Chakrabarti J, Banerji A,
Chatterjee A and Das BR: Curcumin, a potential inhibitor of MMP-2
in human laryngeal squamous carcinoma cells HEp2. J Environ Pathol
Toxicol Oncol. 25:679–690. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Banerji A, Chakrabarti J, Mitra A and
Chatterjee A: Effect of curcumin on gelatinase A (MMP-2) activity
in B16F10 melanoma cells. Cancer Lett. 211:235–242. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hoshino R, Chatani Y, Yamori T, et al:
Constitutive activation of the 41-/43-kDa mitogen-activated protein
kinase signaling pathway in human tumors. Oncogene. 18:813–822.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Y, Zhu Y, Zhang L, et al: Insulin
promotes proliferation, survival and invasion in endometrial
carcinoma by activating the MEK/ERK pathway. Cancer Lett.
322:223–231. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tong JS, Zhang QH, Wang ZB, et al: ER-α36,
a novel variant of ER-α, mediates estrogen-stimulated proliferation
of endometrial carcinoma cells via the PKCδ/ERK pathway. PLoS One.
5:e154082010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang H, Shen B, Swinarska JT, Li W, Xiao
K and He P: 9-Hydroxypheophorbide α-mediated photodynamic therapy
induces matrix metalloproteinase-2 (MMP-2) and MMP-9
down-regulation in Hep-2 cells via ROS-mediated suppression of the
ERK pathway. Photodiagnosis Photodyn Ther. 11:55–62. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shi MD, Shih YW, Lee YS, Cheng YF and Tsai
LY: Suppression of 12-O-tetradecanoylphorbol-13-acetate-induced
MCF-7 breast adenocarcinoma cells invasion/migration by α-tomatine
through activating PKCα/ERK/NF-κB-dependent MMP-2/MMP-9
expressions. Cell Biochem Biophys. 66:161–174. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dong QZ, Wang Y, Tang ZP, et al: Derlin-1
is overexpressed in non-small cell lung cancer and promotes cancer
cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and
MMP-9. Am J Pathol. 182:954–964. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guo Y, Shan Q, Gong Y, et al: Curcumin
induces apoptosis via simultaneously targeting AKT/mTOR and
RAF/MEK/ERK survival signaling pathways in human leukemia THP-1
cells. Pharmazie. 69:229–233. 2014.PubMed/NCBI
|
|
28
|
Xie YQ, Wu XB and Tang SQ: Curcumin
treatment alters ERK-1/2 signaling in vitro and inhibits
nasopharyngeal carcinoma proliferation in mouse xenografts. Int J
Clin Exp Med. 7:108–114. 2014.PubMed/NCBI
|
|
29
|
Mo N, Li ZQ, Li J and Cao YD: Curcumin
inhibits TGF-β1-induced MMP-9 and invasion through ERK and Smad
signaling in breast cancer MDA-MB-231 cells. Asian Pac J Cancer
Prev. 13:5709–5714. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shin HK, Kim J, Lee EJ and Kim SH:
Inhibitory effect of curcumin on motility of human oral squamous
carcinoma YD-10B cells via suppression of ERK and NF-kappaB
activations. Phytother Res. 24:577–582. 2010.PubMed/NCBI
|
